
Hugh Grosvenor Calkins MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Professor of Medicine, Johns Hopkins University School of Medicine; Director, Cardiac Arrhythmia Service, Director, Johns Hopkins ARVD Program, Director, and the Electrophysiology Laboratory.
Join to view full profile
601 North Caroline StreetSuite 7200Baltimore, MD 21287
Phone+1 443-997-0270
Fax+1 410-614-1168
Dr. Calkins is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1986 - 1989
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1986
Harvard Medical SchoolClass of 1983
Certifications & Licensure
MD State Medical License 1992 - 2028
NH State Medical License 2024 - 2024
WI State Medical License 2020 - 2023
NC State Medical License 2020 - 2022
AK State Medical License 2020 - 2021
ME State Medical License 2020 - 2021
OK State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Clinical Cardiac Electrophysiology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- High Intensity Focused Ultrasound (HIFU) Ablation System Study
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13
- Pilot Randomized Trial With Flecainide in ARVC Patients Start of enrollment: 2019 Jul 23
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsExternal validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopat...Alessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, Brittney Murray, Crystal Tichnell
Heart Rhythm. 2026-10-01 - Atrial Fibrillation Ablation Effectiveness End Points, Safety End Points, and Trial Design: Academic Research Consortium Initiative Endorsed by the Heart Rhythm Society.Paul J Wang, Edward P Gerstenfeld, Jonathan P Piccini, Atul Verma, T Jared Bunch
Circulation. Arrhythmia and Electrophysiology. 2026-09-29 - Arrhythmogenic right ventricular cardiomyopathy.Alessio Gasperetti, Cynthia A James, Firat Duru, Peter van Tintelen, Hugh Calkins
European Heart Journal. 2026-09-22
Journal Articles
- Arrhythmic Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy Patients Without Implantable DefibrillatorsHugh Calkins, Jane Crosson, Crystal Tichnell, Jonathan Chrispin, Harikrishna Tandri, Journal of Cardiovascular Electrophysiology
- Integrating New Approaches to Atrial Fibrillation Management: The 6th AFNET/EHRA Consensus ConferenceHugh Calkins, MD, EP Europace
Lectures
- When to Consider Rate Control, Rhythm Control, and Catheter Ablation for AF62nd Annual Scientific Session & Expo, San Francisco, California, USA
- When to Consider Rate Control, Rhythm Control, and Catheter Ablation for AFAmerican College of Cardiology, 62nd Annual Scientific Session & Expo, San Francisco, California, US
- Navigating Recently Updated Atrial Fibrillation Clinical Practice GuidelinesEUROPACE 2013, Athens, Greece
Press Mentions
Holiday Drinking Can Harm Your HeartDecember 1st, 2022
RAFT-AF: No Clear Benefit for Catheter Ablation in HF, but Secondary Outcomes Show PromiseMay 18th, 2021- Blood Biomarkers to Detect New-Onset Atrial Fibrillation and Cardioembolism in Ischemic Stroke PatientsFebruary 6th, 2021
Professional Memberships
- Fellow
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/hugh-calkins
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:

